NCC MEDICAL GROUP is an internationally recognized manufacturer dedicated to neuro-diagnostic and neuro-monitoring technologies. With more than two decades of experience in medical device development and manufacturing, NCC has built a strong reputation for delivering reliable clinical solutions and high-quality medical consumables to healthcare providers worldwide.
Established in 1997, NCC began as a technology-driven enterprise focused on neurophysiology research and electrophysiological diagnostic systems. Over the years, the company has expanded its capabilities to include advanced medical consumables and clinical accessories used in neurological diagnostics, intraoperative monitoring, and hospital procedures. Today, NCC offers a comprehensive portfolio that includes EEG systems, EMG equipment, IONM monitoring platforms, and a variety of medical consumables designed for safe clinical use.
The research and manufacturing center of NCC is located in Shanghai, China, one of the most advanced industrial and technological hubs in the country. This facility integrates engineering research, product design, precision manufacturing, and quality testing into a single operational platform. Through continuous investment in technology and production infrastructure, NCC ensures that its medical devices and consumables meet strict international quality standards.
To strengthen global regulatory compliance and quality assurance, NCC also operates a quality and compliance hub in Singapore. This international center manages regulatory coordination, certification processes, and global quality monitoring. By combining manufacturing expertise in China with global quality management in Singapore, NCC ensures that its products meet the requirements of international healthcare markets.
NCC has been recognized as a National “Little Giant” enterprise under the SRDI program, a prestigious designation awarded to companies demonstrating specialized expertise, refined production capabilities, differentiated technologies, and continuous innovation. This recognition highlights NCC’s commitment to technological advancement and high-precision manufacturing in the medical device industry.
The global operational strategy of NCC is built on three key pillars. The first pillar focuses on research and manufacturing, where engineering teams develop innovative neurophysiology technologies and high-quality medical consumables. The second pillar involves global sales and distribution, supported by a growing network of international partners and distributors. The third pillar focuses on service, training, and innovation through initiatives such as the NeuGuard Service Platform and the NCC Innovation Academy.
Through this integrated structure, NCC products are now used in more than 50 countries worldwide. In China alone, NCC clinical solutions are installed in over 5,000 hospitals, including leading teaching hospitals and regional medical centers. Internationally, NCC continues to expand across Southeast Asia, Australia, Europe, the Americas, and Africa.
NCC’s mission is centered on safeguarding life and health by supporting safer surgeries, accurate diagnostics, and improved patient outcomes. To support healthcare professionals, the company operates more than 30 training and technical support centers throughout China. These centers provide clinical education, technical guidance, and hands-on training for medical staff working with EEG, EMG, and intraoperative monitoring technologies.
By combining advanced manufacturing, global regulatory compliance, and professional training services, NCC MEDICAL GROUP remains committed to delivering dependable medical technologies and supporting healthcare providers around the world.
Copyright © NCC Medical Co., Ltd. - Privacy policy